Cameco's Quagmire of a Quarter

Recs

4

Disney Buys Marvel!

...And David Gardner called it. He's up 1,334%! See what David's recommending that you buy NEXT!

Click here now to find out!

Even the most immovable of miners are suddenly facing some tough times. Once-mighty Teck Cominco (NYSE: TCK) is suddenly holding on for dear life, while Vale (NYSE: RIO) shares are valued at one-quarter of their pre-meltdown price.

Cameco (NYSE: CCJ) is another firm that I never imagined would face such a tough slog, but here we are. The uranium mogul's recent results were mediocre at best.

A lot of folks were downright shocked when the uninterrupted, multiyear uranium-price parabola pulled back a bit last summer. Well, the price for U308's been headed down ever since. This quarter, Cameco registered 30% lower realized prices than in the prior-year period. The comparison is exaggerated by a spot market sale at the market's 2007 peak, but lower prices are certainly unwelcome in the face of rising unit costs.

Cameco's now calling for 15%-20% higher costs this year, rather than a 10%-15% bump. The main culprit has to be production, which is looking bedraggled across the board. Through the first nine months of the year, commercial production is down 19% or so. For the full year, guidance has been lowered by about 10%. That includes volumes at the troublesome Inkai project, which retains its pre-commercial status.

Fans of this firm have to keep an eye on those pounds of production. The gap between Cameco's sales and production, noted by a fellow Fool at this time last year, has widened further, to 12 million pounds. I suppose one upshot of lower spot prices is that the Russians may have less leverage to rejigger their long-term contracts concerning converted nuclear weaponry. But still, we need to see Cameco wean itself off this waning above-ground stockpile.

Much like fellow Saskatchewan slugger PotashCorp (NYSE: POT), Cameco controls an unbelievably strong position with regard to its mineral endowment. I'm not aware of equally rich uranium deposits anywhere else in the world. That asset value, combined with the firm's integration along the entire value chain -- now including enrichment, thanks to an investment in a General Electric (NYSE: GE) / Hitachi (NYSE: HIT) joint venture -- should keep Cameco from plumbing the share-price depths of base metal miners like Teck and Lundin Mining (NYSE: LMC). But if we ever do see Cameco hit single digits, I may be first in line to scoop up shares.

Cameco is rated a regal five stars in Motley Fool CAPS. Are you bullish or bearish on the uranium bruiser? Contribute your own thoughts right here.

Closed for 15 months – opening 10 days only! Get notified ahead of time as our expert portfolio manager invests $1 MILLION in the best opportunities from across The Motley Fool’s premium investment services. This is the first open since August 2008, by invitation only. Enter email below.

Fool contributor Toby Shute is active in CAPS under the name TMFSmashy, but he doesn't have a position in any company mentioned. The Motley Fool has a disclosure policy.

Stock news, financial commentary, and your daily dose of Foolishness: Get plugged in to The Motley Fool on Twitter!

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Compare Brokers

TD AMERITRADE
more info
ShareBuilder
more info
Power E*Trade

more info
Scottrade
more info
Fool Disclosure

DocumentId: 774727, ~/Articles/ArticleHandler.aspx, 11/10/2009 7:05:37 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

The Must-Read Story on Fool.com
Health-Care Reform: A Tale of Two Chambers

Related Tickers

4/1/2009 4:02 PM
LMC $1.64 Down +0.00 +0.00%
Lundin Mining Corp… CAPS Rating: *****
GE $15.85 Up +0.52 +3.39%
General Electric C… CAPS Rating: ****
RIO $17.42 Down +0.00 +0.00%
Vale CAPS Rating: *****
HIT $33.50 Down -0.29 -0.86%
Hitachi, Ltd. (ADR… CAPS Rating: ***
TCK $32.39 Up +1.54 +4.99%
Teck Resources Lim… CAPS Rating: ****
CCJ $29.87 Up +0.83 +2.86%
Cameco Corp (USA) CAPS Rating: *****
POT $99.67 Up +3.42 +3.55%
Potash Corp./Saska… CAPS Rating: ****

Community: Investing Wiki

Term Of The Hour

Biotechnology: Biotechnology uses biological processes to solve problems in such areas as health and medicine, agriculture and manufacturing.

Want to learn more or edit this definition?
Click here to read more!